{"content":"<li class=\"n-box-item date-title\" data-end=\"1494302399\" data-start=\"1494216000\" data-txt=\"Monday, December 23, 2019\">Monday, May  8, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3264851\" data-ts=\"1494289368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264851-marvels-guardians-sequel-blasts-away-from-film-competition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marvel&#39;s &#39;Guardians&#39; sequel blasts away from film competition</a></h4><ul>   <li><i>Guardians of the Galaxy Vol. 2</i> (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-0.5%</font>) opened with a smash, dominating movie spending over the weekend with a domestic opening of $146.5M and drawing multiples of that worldwide.</li>    <li>The film, a sequel to the surprise 2014 smash, added another $285M overseas to total $431.5M globally. It made up 79% of the cumulative top 10 gross overall, Box Office Mojo notes.</li>    <li>It was far ahead of holdover <i>The Fate of the Furious</i> (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+0.5%</font>), which fell off 57% in its fourth week to $8.6M, still good enough for the No. 2 spot; and The Boss Baby (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-1.9%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-2.5%</font>), in third with $5.98M.</li>    <li>The original <i>Guardians of the Galaxy</i> wrapped up with $333.2M domestically and $773.3M as a global total; the sequel's stronger opening (and positive word of mouth) is prompting hopes for another global smash. It drew $48M in its Chinese opening, nearly half of what the first film did overall there.</li><li><em>The Fate of the Furious</em> weekend take was enough to push that film over the $200M domestic mark (to $207M) and make its worldwide take an impressive $1.162B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264851\" data-linked=\"Marvel&#39;s &#39;Guardians&#39; sequel blasts away from film competition\" data-tweet=\"$FOX $FOX $FOXA - Marvel&#39;s &#39;Guardians&#39; sequel blasts away from film competition https://seekingalpha.com/news/3264851-marvels-guardians-sequel-blasts-away-from-film-competition?source=tweet\" data-url=\"https://seekingalpha.com/news/3264851-marvels-guardians-sequel-blasts-away-from-film-competition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264850\" data-ts=\"1494288805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FN\" target=\"_blank\">FN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264850-fabrinetplus-10_7-among-top-gainers-after-q3-revenue-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fabrinet +10.7%, among top gainers after Q3 revenue beat</a></h4><ul>   <li>Fabrinet (<a href=\"http://seekingalpha.com/symbol/FN\" target=\"_blank\">FN</a> <font color='green'>+3.7%</font>) is the second-best postmarket gainer on the NYSE, <font color='green'>up another 10.7%</font> after hours, after posting <a href=\"https://seekingalpha.com/news/3264724-fabrinet-misses-0_08-beats-revenue\" target=\"_blank\">Q3 earnings</a> where revenues beat its own and analysts' expectations.</li>    <li>Net income missed expectations by $0.08/share but rose 46% Y/Y, to $30.5M, including a foreign exchange loss of $3.7M (about $0.10/share impact).</li>    <li>Cash and equivalents came to $136.6M, up from a year-ago $127.96M.</li>    <li>It's guiding to Q4 revenues of $361M-$365M (below consensus for $368.7M) and non-GAAP EPS of $0.82-$0.84 (below an expected $0.88).</li>    <li><a href=\"https://seekingalpha.com/pr/16825333-fabrinet-announces-third-quarter-fiscal-year-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3264850\" data-linked=\"Fabrinet +10.7%, among top gainers after Q3 revenue beat\" data-tweet=\"$FN - Fabrinet +10.7%, among top gainers after Q3 revenue beat https://seekingalpha.com/news/3264850-fabrinetplus-10_7-among-top-gainers-after-q3-revenue-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3264850-fabrinetplus-10_7-among-top-gainers-after-q3-revenue-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264847\" data-ts=\"1494285880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRCP\" target=\"_blank\">PRCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264847-perceptronminus-4_3-revenue-declines-loss-narrows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perceptron -4.3% as revenue declines, loss narrows</a></h4><ul>    <li>Perceptron (NASDAQ:<a href='https://seekingalpha.com/symbol/PRCP' title='Perceptron, Inc.'>PRCP</a>) has <font color='red'>fallen 4.3%</font> after hours after missing on top and bottom lines (vs. one estimate) in its <a href=\"https://seekingalpha.com/news/3264720-perceptron-misses-0_04-misses-revenue\" target=\"_blank\">fiscal Q3 report</a>.</li>    <li>The company's loss narrowed to $0.6M from last year's $2.9M loss, though revenue fell by nearly 10%.</li>    <li>Bookings overall came to $23.2M (up 57%). Bookings by region: Americas, $11.3M; Europe, $7M; Asia, $4.9M.</li>    <li>Cash and short-term investments came to $5.1M, down from $6.3M a year-end 2016.</li>    <li>The company's still confident in 2017 guidance for high single-digit to low double-digit revenue growth, and sees Q4 revenue of $18.5M-$21.5M vs. an expected $18.5M (one estimate).</li>    <li><a href=\"http://investors.perceptron.com/\" target=\"_blank\">Conference call</a> to come tomorrow at 10 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16825349-perceptron-announces-third-quarter-fiscal-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3264847\" data-linked=\"Perceptron -4.3% as revenue declines, loss narrows\" data-tweet=\"$PRCP - Perceptron -4.3% as revenue declines, loss narrows https://seekingalpha.com/news/3264847-perceptronminus-4_3-revenue-declines-loss-narrows?source=tweet\" data-url=\"https://seekingalpha.com/news/3264847-perceptronminus-4_3-revenue-declines-loss-narrows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264845\" data-ts=\"1494284726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264845-verizons-mcadam-no-urgent-need-for-transformative-m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verizon&#39;s McAdam: No urgent need for transformative M&amp;A</a></h4><ul>   <li>Less than a month after saying he'd be <a href=\"https://seekingalpha.com/news/3257694-verizon-gets-lift-ceo-says-talk-merger-comcast-disney-others\" target=\"_blank\">open to merging</a> with Comcast, Disney or most anybody else, Verizon (VZ -0.1%) CEO Lowell McAdam says he <a href=\"http://www.reuters.com/article/us-verizon-m-a-idUSKBN1842ET\" target=\"_blank\">doesn't see an urgent need</a> to hop into bed with a big partner.</li>    <li>Speaking at the company's analyst day, he brushed off analyst speculation (ramping up <a href=\"https://seekingalpha.com/news/3258304-verizon-minus-2_2-percent-core-wireless-customers-drop-first-time\" target=\"_blank\">after poor earnings</a>) that the company needs a transformative deal to succeed.</li>    <li>\"We don't feel the urgency that seems to be out there in the analyst community, the banking community and the media,\" McAdam said.</li>    <li>As for the deal between Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+0.5%</font>) and Charter (<a href=\"http://seekingalpha.com/symbol/CHTR\" target=\"_blank\">CHTR</a> <font color='red'>-3.3%</font>) <a href=\"https://seekingalpha.com/news/3264525-comcast-charter-form-wireless-alliance\" target=\"_blank\">forbidding one another</a> from pairing with Verizon unilaterally, McAdam says that doesn't change the individual relationships; both companies will use Verizon airwaves for their wireless services. \"Frankly, we encouraged them to work together because dealing with one customer is a lot better than dealing with multiple customers,\" McAdam says.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3264407-wsj-comcast-charter-forming-wireless-partnership\" target=\"_blank\">WSJ: Comcast, Charter forming wireless partnership</a> (May. 07 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264845\" data-linked=\"Verizon&#39;s McAdam: No urgent need for transformative M&amp;A\" data-tweet=\"$CMCSA $CMCSA $CHTR - Verizon&#39;s McAdam: No urgent need for transformative M&amp;A https://seekingalpha.com/news/3264845-verizons-mcadam-no-urgent-need-for-transformative-m?source=tweet\" data-url=\"https://seekingalpha.com/news/3264845-verizons-mcadam-no-urgent-need-for-transformative-m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264842\" data-ts=\"1494282098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OAS\" target=\"_blank\">OAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264842-oasis-petroleum-posts-q1-beat-plans-for-ipo-of-midstream-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oasis Petroleum posts Q1 beat, plans for IPO of some midstream assets</a></h4><ul>     <li>Oasis Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/OAS' title='Oasis Petroleum Inc.'>OAS</a>) <font color='green'>+1.9%</font>&nbsp;AH after reporting better than expected <a href=\"https://seekingalpha.com/news/3264829-oasis-petroleum-beats-0_02-beats-revenue\" target=\"_blank\">Q1 earnings</a> and revenues, and plans contribute some of its midstream assets to an MLP, in which it would <a href=\"https://seekingalpha.com/pr/16825494-oasis-petroleum-announces-plans-initial-public-offering-certain-midstream-assets\" target=\"_blank\">sell a minority interest via an IPO</a>.</li><li>The midstream assets that are expected to be part of the MLP are  located in the Williston Basin and  include part of OAS's crude oil gathering and transportation  system, natural gas gathering and processing system, and water  handling systems.</li>     <li>OAS also says it increased Q1 production 19%&nbsp;Q/Q to 63,192 boe/day from 53,150 boe/day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264842\" data-linked=\"Oasis Petroleum posts Q1 beat, plans for IPO of some midstream assets\" data-tweet=\"$OAS - Oasis Petroleum posts Q1 beat, plans for IPO of some midstream assets https://seekingalpha.com/news/3264842-oasis-petroleum-posts-q1-beat-plans-for-ipo-of-midstream-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3264842-oasis-petroleum-posts-q1-beat-plans-for-ipo-of-midstream-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264839\" data-ts=\"1494281213\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264839-pandora-turns-3_7-higher-after-smaller-expected-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora turns 3.7% higher after smaller-than-expected loss</a></h4><ul>     <li>Pandora Media (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) has turned up in postmarket trade (now <font color='green'>+3.7%</font>) as investors digest a newsy release from the company, incorporating its earnings and <a href=\"https://seekingalpha.com/news/3264804-pandora-minus-2-percent-results-kkr-investment-board-exits\" target=\"_blank\">updates on its strategic review</a>.</li>     <li>The company beat expectations by posting a smaller than expected loss, though revenues missed narrowly.</li>     <li>Total subscribers were up about 20% to 4.71M. Since it launched its Pandora Premium service in mid-March, it's seen more than 500,000 Premium trial starts (and about 1.3M trial starts across its tiers).</li>     <li>Nearly half of Pandora Premium trial listeners used the service daily, significantly higher than non-Premium listeners. In advertising, it expects \"strong tailwinds\" as ad tech investments come on line in the seasonally strong second half.</li>     <li>Listener hours -- \"actively managed this quarter to optimize margins in our ad-supported service\" -- were down to 5.21B, from the previous year's 5.52B. Active listeners declined to 76.7M from 79.4M a year ago.</li>     <li>Revenue breakout: Advertising, $223.3M (up 1.4%); Subscription and other, $64.9M (up 18.5%); Ticketing service, $27.8M (up 24.9%).</li>     <li>For Q2, it's guiding to revenue of $360M-$375M -- up about 7% Y/Y at the midpoint, and light of expectations for $389.4M. It expects full-year revenue of $1.5B-$1.65B (vs. consensus for $1.62B).</li>     <li><a href=\"https://seekingalpha.com/pr/16825435-pandora-reports-q1-2017-financial-results\" target=\"_blank\">Earnings press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3264839\" data-linked=\"Pandora turns 3.7% higher after smaller-than-expected loss\" data-tweet=\"$P - Pandora turns 3.7% higher after smaller-than-expected loss https://seekingalpha.com/news/3264839-pandora-turns-3_7-higher-after-smaller-expected-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3264839-pandora-turns-3_7-higher-after-smaller-expected-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264832\" data-ts=\"1494279604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264832-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/ROKA' title='Roka Bioscience'>ROKA</a> <font color='green'>+11.7%</font>. <a href='https://seekingalpha.com/symbol/DHXM' title='DHX Media Ltd Variable Voting'>DHXM</a> <font color='green'>+7.1%</font>. <a href='https://seekingalpha.com/symbol/FN' title='Fabrinet'>FN</a> <font color='green'>+6.3%</font>. <a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a> <font color='green'>+5.0%</font>. <a href='https://seekingalpha.com/symbol/QTNA' title='Quantenna Communications'>QTNA</a> <font color='green'>+5.0%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='red'>-15.7%</font>. <a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a> <font color='red'>-14.8%</font>. <a href='https://seekingalpha.com/symbol/OTEX' title='Open Text Corporation'>OTEX</a> <font color='red'>-9.7%</font>. <a href='https://seekingalpha.com/symbol/ARTX' title='Arotech Corporation'>ARTX</a> <font color='red'>-8.9%</font>. <a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='red'>-7.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264832\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$ROKA $DHXM $FN - After Hours Gainers / Losers https://seekingalpha.com/news/3264832-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3264832-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264829\" data-ts=\"1494279112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OAS\" target=\"_blank\">OAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264829-oasis-petroleum-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oasis Petroleum beats by $0.02, beats on revenue</a></h4><ul><li>Oasis Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/OAS' title='Oasis Petroleum Inc.'>OAS</a>): Q1 EPS of -$0.05 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $285.1M (+118.8% Y/Y) <font color='green'>beats by $32.56M</font>.</li><li>Shares <font color='green'>+1.2%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16825495-oasis-petroleum-inc-announces-quarter-ended-march-31-2017-earnings'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3264829\" data-linked=\"Oasis Petroleum beats by $0.02, beats on revenue\" data-tweet=\"$OAS - Oasis Petroleum beats by $0.02, beats on revenue https://seekingalpha.com/news/3264829-oasis-petroleum-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3264829-oasis-petroleum-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264804\" data-ts=\"1494277615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KKR\" target=\"_blank\">KKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264804-pandoraminus-2-after-results-kkr-investment-board-exits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora -2% after results, KKR investment, board exits</a></h4><ul>   <li>Pandora Media (<a href=\"http://seekingalpha.com/symbol/P\" target=\"_blank\">P</a> <font color='red'>-2.6%</font>) is <font color='red'>off another 2%</font> postmarket following its <a href=\"https://seekingalpha.com/news/3264788-pandora-media-beats-0_10-misses-revenue\" target=\"_blank\">Q1 report</a>, complete with a miss on revenues, the resignation of a pair of directors and a new infusion from KKR.</li>    <li><a href='https://seekingalpha.com/symbol/KKR' title='KKR'>KKR</a> is <a href=\"https://seekingalpha.com/pr/16825440-b-pandora-b-announces-150-million-investment-kkr\" target=\"_blank\">putting in a $150M strategic investment</a>, and the firm's Richard Sarnoff will join Pandora's board. KKR will buy a new designated Series A convertible preferred stock, to earn annual dividends of 7.5% (cash) or 8% (in kind).</li>    <li>Meanwhile, in discussing its ongoing strategic review, it said James M.P. Feuille and Peter Gotcher <a href=\"https://seekingalpha.com/pr/16825445-b-pandora-b-announces-new-governance-measures-confirms-ongoing-strategic-review\" target=\"_blank\">would resign their board seats</a>. An independent committee will seek new directors, and the board will recommend that the board be declassified and set for annual elections in the future.</li>    <li><a href=\"https://seekingalpha.com/pr/16825435-pandora-reports-q1-2017-financial-results\" target=\"_blank\">Earnings Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3264804\" data-linked=\"Pandora -2% after results, KKR investment, board exits\" data-tweet=\"$KKR $KKR $P - Pandora -2% after results, KKR investment, board exits https://seekingalpha.com/news/3264804-pandoraminus-2-after-results-kkr-investment-board-exits?source=tweet\" data-url=\"https://seekingalpha.com/news/3264804-pandoraminus-2-after-results-kkr-investment-board-exits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264791\" data-ts=\"1494277141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTEX\" target=\"_blank\">OTEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264791-open-textminus-10-after-miss-on-profits-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Open Text -10% after miss on profits, revenues</a></h4><ul>   <li>Open Text (NASDAQ:<a href='https://seekingalpha.com/symbol/OTEX' title='Open Text Corporation'>OTEX</a>) has <font color='red'>slid 10.1%</font> in postmarket action after its <a href=\"https://seekingalpha.com/news/3264688-open-text-misses-0_05-misses-revenue\" target=\"_blank\">fiscal Q3 earnings</a> came up short on top and bottom lines.</li>    <li>Revenue grew nearly 35% but missed, and EPS missed despite 12.5% Y/Y growth there.</li>    <li>Operating cash flow slipped nearly 18%, to $156.3M.</li>    <li>\"We have invested approximately $2.4 billion in acquisitions over the last twelve months, and while the financial benefits are evident in our quarterly results, they are yet to be fully realized,\" says CEO/CTO Mark Barrenechea.</li>    <li>Revenue by segment: Cloud services and subscriptions, $177.1M (up 20.1%); Customer Support, $263.4M (up 43.5%); Professional services and other, $65.4M (up 45.2%); License, $87.2M (up 35.5%).</li>    <li>The company boosted its quarterly dividend by 15%.</li>    <li><a href=\"http://investors.opentext.com/events.cfm\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16825223-opentext-reports-third-quarter-fiscal-year-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3264791\" data-linked=\"Open Text -10% after miss on profits, revenues\" data-tweet=\"$OTEX - Open Text -10% after miss on profits, revenues https://seekingalpha.com/news/3264791-open-textminus-10-after-miss-on-profits-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3264791-open-textminus-10-after-miss-on-profits-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264785\" data-ts=\"1494276790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEZS\" target=\"_blank\">AEZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264785-aeterna-zentaris-misses-0_01-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AEterna Zentaris misses by $0.01, misses on revenue</a></h4><ul><li>AEterna Zentaris (NASDAQ:<a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a>): Q1 EPS of -$0.31 <font color='red'>misses by $0.01</font>.</li><li>Revenue of $0.26M (+8.3% Y/Y) <font color='red'>misses by $0.64M</font>.</li><li>Shares <font color='green'>+4.4%</font>.</li><li><a href='https://seekingalpha.com/pr/16825379-aeterna-zentaris-reports-first-quarter-2017-financial-operating-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3264785\" data-linked=\"AEterna Zentaris misses by $0.01, misses on revenue\" data-tweet=\"$AEZS - AEterna Zentaris misses by $0.01, misses on revenue https://seekingalpha.com/news/3264785-aeterna-zentaris-misses-0_01-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3264785-aeterna-zentaris-misses-0_01-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264778\" data-ts=\"1494276341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNLF\" target=\"_blank\">SSNLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264778-wsj-amazon-echo-screen-calling-ability-may-come-tomorrow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Amazon Echo with screen, calling ability may come tomorrow</a></h4><ul>   <li>Amazon.com (<a href=\"http://seekingalpha.com/symbol/AMZN\" target=\"_blank\">AMZN</a> <font color='green'>+1.6%</font>) is set as soon as tomorrow to unveil a new version of its Echo smart speaker, <a href=\"https://www.wsj.com/articles/amazon-plans-to-unveil-new-echo-1494272821\" target=\"_blank\">featuring a touch screen</a> and the ability to make Internet phone calls, <i>The Wall Street Journal</i> reports.</li>    <li>The news comes hot on the heels of word that a Samsung (<a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>) smart speaker to come this fall would <a href=\"https://seekingalpha.com/news/3264666-microsoft-samsung-launch-call-capable-smart-speaker\" target=\"_blank\">feature calling capability</a> through Microsoft's (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) Cortana assistant and Skype service.</li>    <li>An Echo with a 7-inch screen and calling capability would keep Amazon in the lead in the burgeoning category. It holds about 71% of the market, according to eMarketer.</li>    <li>The new Echo is expected to come at more than $200, vs. the screenless Echo, usually selling for $180 (and now on sale for $150).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3260780-cnet-amazon-pursuing-launch-echo-device-video-screen\" target=\"_blank\">CNET: Amazon pursuing launch of Echo device with video screen</a> (Apr. 27 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264778\" data-linked=\"WSJ: Amazon Echo with screen, calling ability may come tomorrow\" data-tweet=\"$SSNLF $SSNLF $MSFT - WSJ: Amazon Echo with screen, calling ability may come tomorrow https://seekingalpha.com/news/3264778-wsj-amazon-echo-screen-calling-ability-may-come-tomorrow?source=tweet\" data-url=\"https://seekingalpha.com/news/3264778-wsj-amazon-echo-screen-calling-ability-may-come-tomorrow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264773\" data-ts=\"1494276112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264773-hertz-skids-after-reporting-wider-loss-anticipated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz skids after reporting wider loss than anticipated</a></h4><ul> <li>Shares of Hertz Global (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>) skid lower after the company reports a wider&nbsp;<a href=\"https://seekingalpha.com/pr/16825356-hertz-global-holdings-reports-first-quarter-2017-financial-results\" target=\"_blank\">Q1 loss</a> than expected.</li> <li>U.S. rental transaction days were down 1% and pricing was 3% lower during the quarter.</li> <li>Fleet investments, IT spending and vehicle realignment initiatives all cut into EBITDA in the U.S., while the international RAC business generated a $3M positive EBITDA return.</li> <li>Shares of Hertz are <font color='red'>down 14.15%</font> AH to $12.80.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264773\" data-linked=\"Hertz skids after reporting wider loss than anticipated\" data-tweet=\"$HTZ - Hertz skids after reporting wider loss than anticipated https://seekingalpha.com/news/3264773-hertz-skids-after-reporting-wider-loss-anticipated?source=tweet\" data-url=\"https://seekingalpha.com/news/3264773-hertz-skids-after-reporting-wider-loss-anticipated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264743\" data-ts=\"1494275264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEET\" target=\"_blank\">MEET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264743-meet-groupminus-6_8-net-income-dips\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meet Group -6.8% as net income dips</a></h4><ul>   <li>Meet Group (<a href=\"http://seekingalpha.com/symbol/MEET\" target=\"_blank\">MEET</a> <font color='green'>+3.6%</font>) -- up to a nine-month high in regular trading -- has <font color='red'>slipped 6.8%</font> after hours following an in-line <a href=\"https://seekingalpha.com/news/3264692-meet-group-eps-line-beats-revenue\" target=\"_blank\">Q1 earnings report</a> where net income fell on a headline basis.</li>    <li>Revenue rose 51%, but GAAP net income fell to $0.4M from a year-ago $2.4M. On a non-GAAP basis, net income rose 21%, and EBITDA of $4.8M was up 30% (24% margin).</li>    <li>Mobile revenue growth of 61% was driven by increases to mobile impressions driven by the Skout acquisition, CFO David Clark notes.</li>    <li>Cash and equivalents came to $74.5M as of March 31; $60M of that was used to acquire Ifwe on April 3.</li>    <li><a href=\"http://www.themeetgroup.com\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16825255-meet-group-reports-first-quarter-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3264743\" data-linked=\"Meet Group -6.8% as net income dips\" data-tweet=\"$MEET - Meet Group -6.8% as net income dips https://seekingalpha.com/news/3264743-meet-groupminus-6_8-net-income-dips?source=tweet\" data-url=\"https://seekingalpha.com/news/3264743-meet-groupminus-6_8-net-income-dips\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264735\" data-ts=\"1494275086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMC\" target=\"_blank\">AMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264735-amc-entertainment-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMC Entertainment EPS in-line, beats on revenue</a></h4><ul><li>AMC Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a>): Q1 EPS of $0.07 in-line.</li><li>Revenue of $1.28B (+67.1% Y/Y) <font color='green'>beats by $30M</font>.</li><li>Shares <font color='green'>+4.17%</font>.</li><li><a href='https://seekingalpha.com/pr/16825327-amc-entertainment-holdings-inc-announces-record-first-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3264735\" data-linked=\"AMC Entertainment EPS in-line, beats on revenue\" data-tweet=\"$AMC - AMC Entertainment EPS in-line, beats on revenue https://seekingalpha.com/news/3264735-amc-entertainment-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3264735-amc-entertainment-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264728\" data-ts=\"1494274959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPLO\" target=\"_blank\">DPLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264728-diplomat-pharmacy-beats-0_04-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diplomat Pharmacy beats by $0.04,  revenue in-line</a></h4><ul><li>Diplomat Pharmacy (NYSE:<a href='https://seekingalpha.com/symbol/DPLO' title='Diplomat Pharmacy'>DPLO</a>): Q1 EPS of $0.19 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $1.08B (+8.4% Y/Y) in-line.</li><li>Shares <font color='green'>+1.6%</font>.</li><li><a href='https://seekingalpha.com/pr/16825361-diplomat-announces-1st-quarter-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3264728\" data-linked=\"Diplomat Pharmacy beats by $0.04,  revenue in-line\" data-tweet=\"$DPLO - Diplomat Pharmacy beats by $0.04, revenue in-line https://seekingalpha.com/news/3264728-diplomat-pharmacy-beats-0_04-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3264728-diplomat-pharmacy-beats-0_04-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264693\" data-ts=\"1494274007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLA\" target=\"_blank\">DLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264693-margins-improve-delta-apparel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Margins improve at Delta Apparel</a></h4><ul> <li>Delta Apparel (NYSEMKT:<a href='https://seekingalpha.com/symbol/DLA' title='Delta Apparel, Inc'>DLA</a>) reports says the Sports Authority bankruptcy and a lower level of sales for the Junkfood business contributed to a drop in revenue in <a href=\"https://seekingalpha.com/pr/16825209-delta-apparel-reports-fiscal-2017-second-quarter-six-month-results\" target=\"_blank\">FQ2</a>.</li> <li>However, operating profit as a percentage of sales improved 180 bps to 7.2% of sales.</li> <li>\"We expect Salt Life and Art Gun to achieve record revenue in 2017 and should see continued improvement in Activewear with its expanded product offerings,\" says CEO Robert Humphreys in a look ahead.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3264676-delta-apparel-beats-0_03-misses-revenue\" target=\"_blank\">Delta Apparel beats by $0.03, misses on revenue</a> (May 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264693\" data-linked=\"Margins improve at Delta Apparel\" data-tweet=\"$DLA - Margins improve at Delta Apparel https://seekingalpha.com/news/3264693-margins-improve-delta-apparel?source=tweet\" data-url=\"https://seekingalpha.com/news/3264693-margins-improve-delta-apparel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264701\" data-ts=\"1494273574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITE\" target=\"_blank\">KITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264701-kite-pharmas-woes-drags-down-broader-biotech-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kite Pharma&#39;s woes drags down broader biotech sector</a></h4><ul>     <li>Kite Pharmaceuticals (<a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a> <font color='red'>-13.2%</font>) remains sharply lower after reporting a <a href=\"https://seekingalpha.com/news/3264592-kite-pharma-minus-11-percent-patient-dies-kte-c19-safety-study\" target=\"_blank\">patient death in a clinical study</a> for its lead drug candidate, even though analysts at Cowen and some other places are <a href=\"https://seekingalpha.com/news/3264644-cowen-recommends-buying-dip-kite-pharma\" target=\"_blank\">out in defense</a> of the company.</li>     <li>Raymond James downgrades shares to Market Perform from Outperform, not so much because of the death but the expectations for KTE-C19's  commercial prospects <a href=\"http://thefly.com/landingPageNews.php?id=2548432&amp;headline=KITE-Raymond-James-downgrades-Kite-Pharma-on-valuation-amid--selloff\" target=\"_blank\">largely are priced in</a> at current share levels.</li>     <li>The news has <a href=\"http://www.barrons.com/articles/kite-pharma-crashes-takes-other-biotechs-with-it-1494271916\" target=\"_blank\">weighed down shares</a> of other drug makers focused on immunononcology therapies, such as Juno Therapeutics (<a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='red'>-6.6%</font>), Tesaro (<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='red'>-5.7%</font>) and Incyte (<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='red'>-3.8%</font>); the Nasdaq Biotech ETF (<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='red'>-2.2%</font>) swirls down to lows of the day.</li>     <li>Also, biotech execs including the CEOs of Vertex Pharma (<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color='green'>+0.2%</font>), Regeneron (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='red'>-1.3%</font>) and Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-3.5%</font>) plus the head of the National Institutes of Health are meeting with White House officials to <a href=\"https://www.bloomberg.com/news/articles/2017-05-08/biotech-ceos-nih-defend-research-spending-at-white-house-visit\" target=\"_blank\">defend government sponsored research</a> in the wake of Pres. Trump's budget proposal seeking deep cuts.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264701\" data-linked=\"Kite Pharma&#39;s woes drags down broader biotech sector\" data-tweet=\"$KITE $KITE $JUNO - Kite Pharma&#39;s woes drags down broader biotech sector https://seekingalpha.com/news/3264701-kite-pharmas-woes-drags-down-broader-biotech-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3264701-kite-pharmas-woes-drags-down-broader-biotech-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264670\" data-ts=\"1494272736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264670-verizon-in-300m-deal-to-buy-optical-fiber-from-prysmian\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verizon in $300M deal to buy optical fiber from Prysmian</a></h4><ul>    <li>In its second major optical-cable deal in a month, Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='red'>-0.3%</font>) has <a href=\"http://www.fiercetelecom.com/telecom/verizon-signs-300m-optical-component-purchase-prysmian\" target=\"_blank\">signed a $300M deal</a> to make Prysmian (<a href=\"http://seekingalpha.com/symbol/PRYMY\" target=\"_blank\">PRYMY</a> <font color='green'>+2.2%</font>) a supplier to help feed its expansion plans.</li>    <li>The three-year deal will see the North American unit of the Italian cable specialist supplying Verizon with more than 17M km (10.6M miles) of cable.</li>    <li>That will lead to a major investment in Prysmian North America from its parent. The deal \"helps ensure we can ramp supply in order to expand our network capacity and speed 5G deployment,\" says Verizon Chief Supply Chain Officer Viji Menon.</li>    <li>In mid-April, Verizon agreed to a <a href=\"https://seekingalpha.com/news/3257619-corning-jumps-verizon-agrees-fiber-deal-least-1_05b\" target=\"_blank\">billion-dollar deal</a> to buy millions of miles of fiber from Corning in order to grow its FiOS platform.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264670\" data-linked=\"Verizon in $300M deal to buy optical fiber from Prysmian\" data-tweet=\"$VZ $VZ $PRYMY - Verizon in $300M deal to buy optical fiber from Prysmian https://seekingalpha.com/news/3264670-verizon-in-300m-deal-to-buy-optical-fiber-from-prysmian?source=tweet\" data-url=\"https://seekingalpha.com/news/3264670-verizon-in-300m-deal-to-buy-optical-fiber-from-prysmian\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264668\" data-ts=\"1494271824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOG\" target=\"_blank\">NOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264668-northern-oil-gasplus-10-on-q1-earnings-beat-strong-production-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Oil &amp; Gas +10% on Q1 earnings beat, strong production results</a></h4><ul>     <li>Northern Oil &amp;&nbsp;Gas (<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+10.3%</font>) surges by more than 10% after beating analyst estimates for <a href=\"https://seekingalpha.com/news/3264441-northern-oil-and-gas-beats-0_02-beats-revenue\" target=\"_blank\">Q1 earnings</a> as revenue more than doubled from year-ago levels.</li>     <li>NOG says it produced just under 1.2M boe/day, or an average of 13,299 bbl/day, and new wells added in Q1 averaged 1,485 boe/day during their first 30 days in operation, a 34% increase over new wells during the same period last year.</li><li>NOG says its ability to allocate capex to the highest return  wells is allowing it to maintain production  levels despite dramatic capex reductions since 2015.</li><li>Separately, investor Bahram Akradi <a href=\"https://www.streetinsider.com/SEC+Filings/Form+SC+13DA+NORTHERN+OIL+%26amp%3B+GAS%2C+INC.+Filed+by%3A+Akradi+Bahram/12872310.html\" target=\"_blank\">discloses</a> an increased active stake in NOG to 8.58% from 7.5% prior.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264668\" data-linked=\"Northern Oil &amp; Gas +10% on Q1 earnings beat, strong production results\" data-tweet=\"$NOG - Northern Oil &amp; Gas +10% on Q1 earnings beat, strong production results https://seekingalpha.com/news/3264668-northern-oil-gasplus-10-on-q1-earnings-beat-strong-production-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3264668-northern-oil-gasplus-10-on-q1-earnings-beat-strong-production-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264667\" data-ts=\"1494271704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDI\" target=\"_blank\">CDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264667-celadon-comes-storming-back\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celadon comes storming back</a></h4><ul> <li>Celadon (NYSE:<a href='https://seekingalpha.com/symbol/CDI' title='CDI Corporation'>CDI</a>) is <font color='green'>up 27%</font> as shares make a spirited comeback from their huge slide last week.</li> <li>The company is looking to <a href=\"http://www.thetrucker.com/News/Story/Celadonsaysitwillrefocusoncoretruckingoperations\" target=\"_blank\">shift</a> its focus to core trucking operations and use company drivers instead of independent contractors.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3262152-celadon-minus-30-percent-prior-financial-reports-longer-relied-upon\" target=\"_blank\">Celadon -30% as prior financial reports should no longer be relied upon</a> (May 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3262888-sa-contributor-schools-wall-street-firms-celadon\" target=\"_blank\">SA contributor schools Wall Street firms on Celadon</a> (May 3)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3264667\" data-linked=\"Celadon comes storming back\" data-tweet=\"$CDI - Celadon comes storming back https://seekingalpha.com/news/3264667-celadon-comes-storming-back?source=tweet\" data-url=\"https://seekingalpha.com/news/3264667-celadon-comes-storming-back\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264666\" data-ts=\"1494271616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNLF\" target=\"_blank\">SSNLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264666-microsoft-samsung-to-launch-call-capable-smart-speaker\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft, Samsung to launch call-capable smart speaker</a></h4><ul>   <li>Microsoft's (<a href=\"http://seekingalpha.com/symbol/MSFT\" target=\"_blank\">MSFT</a> <font color='red'>-0.3%</font>) move into \"smart speakers\" is <a href=\"https://www.wsj.com/articles/microsoft-cortana-powered-speaker-challenges-amazons-echo-with-skype-calls-1494269144\" target=\"_blank\">headed for launch this fall</a>, via a device from Samsung (<a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>).</li>    <li>The Invoke is set to launch this fall, into a market already occupied by Amazon.com's (<a href=\"http://seekingalpha.com/symbol/AMZN\" target=\"_blank\">AMZN</a> <font color='green'>+1.2%</font>) Echo device from two years ago, and Google Home (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+0.9%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+0.9%</font>), released last fall.</li>    <li>But the new device is set to use Microsoft's Cortana digital assistant to make phone calls, using integration with Microsoft's Skype. And its development by Samsung unit Harmon Kardon has the parent pointing to HK's heritage of audio quality.</li>    <li>Amazon and Google are considering a call feature for their products, and Apple (<a href=\"http://seekingalpha.com/symbol/AAPL\" target=\"_blank\">AAPL</a> <font color='green'>+2.8%</font>) is still rumored to be working on a Siri-powered smart speaker of its own. The Amazon Echo holds about 71% market share, with Google Home taking another 24%, according to eMarketer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264666\" data-linked=\"Microsoft, Samsung to launch call-capable smart speaker\" data-tweet=\"$SSNLF $SSNLF $GOOG - Microsoft, Samsung to launch call-capable smart speaker https://seekingalpha.com/news/3264666-microsoft-samsung-to-launch-call-capable-smart-speaker?source=tweet\" data-url=\"https://seekingalpha.com/news/3264666-microsoft-samsung-to-launch-call-capable-smart-speaker\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264662\" data-ts=\"1494270072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264662-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='green'>+125%</font>. <a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/GIMO' title='Gigamon, Inc.'>GIMO</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/TSEM' title='Tower Semiconductor Ltd.'>TSEM</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/INOD' title='Innodata Inc.'>INOD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AUO' title='AU Optronics Corp.'>AUO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CPSH' title='CPS Technologies Corp.'>CPSH</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264662\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$INPX $STRP $GIMO - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3264662-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3264662-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264658\" data-ts=\"1494269787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGR\" target=\"_blank\">RGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264658-gun-stocks-fall-ahead-of-sturm-ruger-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gun stocks fall ahead of Sturm Ruger earnings</a></h4><ul> <li>Sturm Ruger (<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a> <font color='red'>-3.7%</font>) and American Outdoor Brands (<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='red'>-1.6%</font>) trade weak ahead of Sturm Ruger's earnings report. The company is expected to update on demand and inventory issues along with its headline numbers (Consensus: $162M revenue, $0.98 EPS).</li> <li>Post-election returns: Stumr Ruger -10%, American Outdoor -26%.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3264658\" data-linked=\"Gun stocks fall ahead of Sturm Ruger earnings\" data-tweet=\"$RGR $RGR $AOBC - Gun stocks fall ahead of Sturm Ruger earnings https://seekingalpha.com/news/3264658-gun-stocks-fall-ahead-of-sturm-ruger-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3264658-gun-stocks-fall-ahead-of-sturm-ruger-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264656\" data-ts=\"1494268768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIRB\" target=\"_blank\">AIRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264656-report-airbnb-to-lease-huge-space-from-zynga-hq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Airbnb to lease huge space from Zynga HQ</a></h4><ul>   <li>Zynga (<a href=\"http://seekingalpha.com/symbol/ZNGA\" target=\"_blank\">ZNGA</a> <font color='green'>+2.5%</font>) is set to lease about 250,000 square feet of its HQ to Airbnb (<a href='https://seekingalpha.com/symbol/AIRB' title='Airbnb, Inc.'>AIRB</a>) in what would be San Francisco's <a href=\"https://www.theinformation.com/airbnb-negotiating-big-sf-office-expansion?shared=c61a97\" target=\"_blank\">biggest office lease this year</a>, The Information reports.</li>    <li>That's about 37% of the space. Terms aren't clear, the report says, but the lease could cost Airbnb about $15M/year based on neighborhood rents.</li>    <li>Airbnb would get solid room to grow ahead of a possible public float next year.</li>    <li>Zynga bought the elaborate headquarters in 2012 for $228M, and began <a href=\"https://seekingalpha.com/news/3140516-zynga-4_1-percent-mulls-drawing-big-gain-hq-sale\" target=\"_blank\">looking at a sale</a> earlier this year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264656\" data-linked=\"Report: Airbnb to lease huge space from Zynga HQ\" data-tweet=\"$AIRB $AIRB $ZNGA - Report: Airbnb to lease huge space from Zynga HQ https://seekingalpha.com/news/3264656-report-airbnb-to-lease-huge-space-from-zynga-hq?source=tweet\" data-url=\"https://seekingalpha.com/news/3264656-report-airbnb-to-lease-huge-space-from-zynga-hq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264654\" data-ts=\"1494267521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264654-ptc-therapeutics-sees-emflaza-net-price-of-35k-annually-per-patient\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PTC Therapeutics sees Emflaza net price of $35K annually per patient</a></h4><ul>     <li>PTC&nbsp;Therapeutics (<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='red'>-10.8%</font>) says it will <a href=\"http://www.marketwatch.com/story/ptc-therapeutics-dmd-drug-emflaza-to-cost-35000-a-year-and-launch-within-the-coming-week-2017-05-08\" target=\"_blank\">receive a net price of $35K per year per patient</a> for Emflaza, the Duchenne muscular dystrophy drug it <a href=\"https://seekingalpha.com/news/3258493-ptc-completes-acquisition-marathons-dmd-med-emflaza\" target=\"_blank\">acquired</a> from Marathon Pharmaceuticals, which had announced a wholesale list price of $89K annually for the drug after it was approved by the FDA in February.</li>     <li>PTCT did not explain in its <a href=\"https://seekingalpha.com/article/4070642-ptc-therapeutics-ptct-ceo-stuart-peltz-q1-2017-results-earnings-call-transcript\" target=\"_blank\">earnings conference call</a> how it calculated the $35K net price other than to say the price reflected how much it expected to receive from a typical pediatric patient weighing 25 kg (~55 lbs.), and the information is <a href=\"https://www.wsj.com/articles/ptc-expects-net-price-of-35-000-annually-per-patient-for-emflaza-1494254575\" target=\"_blank\">sparking confusion</a> among some patients&rsquo; families over the tie to patients&rsquo; weight.</li>     <li>The announcement also fails to ease the concerns of some federal lawmakers who had criticized Marathon&rsquo;s $89K list price.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264654\" data-linked=\"PTC Therapeutics sees Emflaza net price of $35K annually per patient\" data-tweet=\"$PTCT - PTC Therapeutics sees Emflaza net price of $35K annually per patient https://seekingalpha.com/news/3264654-ptc-therapeutics-sees-emflaza-net-price-of-35k-annually-per-patient?source=tweet\" data-url=\"https://seekingalpha.com/news/3264654-ptc-therapeutics-sees-emflaza-net-price-of-35k-annually-per-patient\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264651\" data-ts=\"1494266455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264651-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KOS' title='Kosmos Energy'>KOS</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ALDW' title='Alon USA Partners'>ALDW</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/AREX' title='Approach Resources Inc.'>AREX</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KOP' title='Koppers Holdings Inc.'>KOP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AAU' title='Almaden Minerals Ltd'>AAU</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264651\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$KOS $NAK $ALDW - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3264651-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3264651-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264649\" data-ts=\"1494266416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264649-appleplus-3_1-drexel-bulls-up-suppliers-reportedly-starting-early\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple +3.1% as Drexel bulls up; suppliers reportedly starting early</a></h4><ul>   <li>Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) is <font color='green'>up 3.1%</font> to an all-time high after getting a heavy price target from Drexel Hamilton, and amid news that some iPhone suppliers are ramping up earlier than expected.</li>    <li>Drexel's Brian White has boosted the firm's price target for Apple to $202, highest among analysts, from $185, pointing to improving sentiment on the stock, \"among the most underappreciated\" in the world. Investors are likely to look past summer numbers toward the iPhone 8 and more news about capital distribution.</li>    <li>The $202 target implies 31.6% upside from today's higher price.</li>    <li>Meanwhile, a Chinese report pointed to by Bloomberg says some circuit board makers will begin work for the iPhone 8 in June, a month earlier than expected. Kinsus Interconnect and Zhen Ding are getting started early, according to Taipei's Economic Daily News; Taiwan Semiconductor Manufacturing is starting volume production of A11 chips for the next iPhone in late July, on track for a September unveiling and October on-sale.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264649\" data-linked=\"Apple +3.1% as Drexel bulls up; suppliers reportedly starting early\" data-tweet=\"$AAPL - Apple +3.1% as Drexel bulls up; suppliers reportedly starting early https://seekingalpha.com/news/3264649-appleplus-3_1-drexel-bulls-up-suppliers-reportedly-starting-early?source=tweet\" data-url=\"https://seekingalpha.com/news/3264649-appleplus-3_1-drexel-bulls-up-suppliers-reportedly-starting-early\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264648\" data-ts=\"1494266235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HHC\" target=\"_blank\">HHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264648-howard-hughesplus-4-after-ira-sohn-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Howard Hughes +4% after Ira Sohn mention</a></h4><ul> <li>Howard Hughes (NYSE:<a href='https://seekingalpha.com/symbol/HHC' title='The Howard Hughes Corporation'>HHC</a>) <font color='green'>spikes 3.75%</font> after the stock is mentioned at the Ira Sohn conference. Shares of HHC&nbsp;hit a 52-week high of $128.00.</li> <li>Seeking Alpha's live stream of the event is <a href=\"https://seekingalpha.com/news/3264621-live-ira-sohn-updates\" target=\"_blank\">here</a>.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3264648\" data-linked=\"Howard Hughes +4% after Ira Sohn mention\" data-tweet=\"$HHC - Howard Hughes +4% after Ira Sohn mention https://seekingalpha.com/news/3264648-howard-hughesplus-4-after-ira-sohn-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/3264648-howard-hughesplus-4-after-ira-sohn-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264646\" data-ts=\"1494265446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRXL\" target=\"_blank\">PRXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264646-paraexel-jumps-after-wsj-buyout-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Paraexel jumps after WSJ buyout report</a></h4><ul><li>Parexel International (<a href='https://seekingalpha.com/symbol/PRXL' title='PAREXEL International Corporation'>PRXL</a> <font color='green'>+7.7%</font>) spikes after The Wall Street Journal <a href=\"https://www.wsj.com/articles/parexel-international-explores-sale-1494263796\" target=\"_blank\">reports</a> that the company is exploring a sale.</li><li>Sources say the company has bankers helping it in the process of talking to potential bidders, including private equity firms.</li><li>A valuation as high as $4B for Parexel is anticipated.</li><li>Activist investor Corvex Management holds a sizable stake in Parexel.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264646\" data-linked=\"Paraexel jumps after WSJ buyout report\" data-tweet=\"$PRXL - Paraexel jumps after WSJ buyout report https://seekingalpha.com/news/3264646-paraexel-jumps-after-wsj-buyout-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3264646-paraexel-jumps-after-wsj-buyout-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264644\" data-ts=\"1494264815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITE\" target=\"_blank\">KITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264644-cowen-recommends-buying-dip-in-kite-pharma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen recommends buying the dip in Kite Pharma</a></h4><ul>     <li>Cowen thinks the sharp drop in Kite Pharma (<a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a> <font color='red'>-10.9%</font>) provides a <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/05/9420588/analyst-kite-pharmas-car-t-patient-death-stock-selloff-i\" target=\"_blank\">buying opportunity</a>. The company reported a patient death earlier today and below-consensus Q1 earnings.</li>     <li>The firm points to the significant efficacy benefits of KTE-C19 and the billion dollar opportunity for its upcoming treatment for diffuse large B-cell lymphoma.</li><li>Canaccord <a href=\"https://twitter.com/thenotablecalls/status/861594555875028992\" target=\"_blank\">also recommends buying</a> on weakness, noting the fatality occurred in a very sick patient.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3264592-kite-pharma-minus-11-percent-patient-dies-kte-c19-safety-study\" target=\"_blank\">Kite Pharma -11% as patient dies in KTE-C19 safety study</a> (May 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3264513-kite-pharma-misses-0_02-misses-revenue\" target=\"_blank\">Kite Pharma misses by $0.02, misses on revenue</a> (May 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264644\" data-linked=\"Cowen recommends buying the dip in Kite Pharma\" data-tweet=\"$KITE - Cowen recommends buying the dip in Kite Pharma https://seekingalpha.com/news/3264644-cowen-recommends-buying-dip-in-kite-pharma?source=tweet\" data-url=\"https://seekingalpha.com/news/3264644-cowen-recommends-buying-dip-in-kite-pharma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264636\" data-ts=\"1494263455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264636-financials-top-5-gainers-losers-of-1-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:10 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WRLD' title='World Acceptance Corporation'>WRLD</a> <font color='green'>+12%</font>. CCP <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ONDK' title='OnDeck Capital'>ONDK</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CS' title='Credit Suisse Group AG'>CS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='red'>-6%</font>. DDR <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264636\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:10 PM\" data-tweet=\"$WRLD $SBRA $ONDK - Financials - Top 5 Gainers / Losers as of 1:10 PM https://seekingalpha.com/news/3264636-financials-top-5-gainers-losers-of-1-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3264636-financials-top-5-gainers-losers-of-1-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264665\" data-ts=\"1494263244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRS\" target=\"_blank\">AMRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264665-amyrisminus-38-on-planned-equity-offerings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris -38% on planned equity offerings</a></h4><ul>     <li>Amyris (<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color='red'>-37.5%</font>) plunges nearly 40% after announcing agreements for <a href=\"https://seekingalpha.com/pr/16824373-amyris-announces-agreements-95-million-equity-financing-process-initiative-significantly\" target=\"_blank\">as much as $95M in equity financing</a>, consisting of a direct offering of convertible preferred stock and  private placements of convertible preferred stock and warrants.</li>     <li>Also, Dutch supplements and materials maker Royal DSM (<a href='https://seekingalpha.com/symbol/RDSMY' title='Royal DSM NV ADR'>OTCQX:RDSMY</a>) <a href=\"https://seekingalpha.com/pr/16824370-royal-dsm-make-equity-investment-amyris-purpose-establishing-long-term-relationship\" target=\"_blank\">agrees to invest an initial $25M</a> into AMRS as part of the financing, and may invest an additional $25M subject to certain conditions.</li>     <li>AMRS says the deals of part of its process of reducing debt by ~$75M.</li>     <li>Analysts at Cowen maintain their Market Perform rating on AMRS but <a href=\"http://timesofindia.indiatimes.com/business/international-business/amyris-inc-shares-fall-on-planned-equity-offerings/articleshow/58580611.cms\" target=\"_blank\">cuts its stock price target to $1</a> from $1.50 to reflect the \"dilution associated with the deal (with Royal DSM) and other debt reduction initiatives.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264665\" data-linked=\"Amyris -38% on planned equity offerings\" data-tweet=\"$AMRS $AMRS $RDSMY - Amyris -38% on planned equity offerings https://seekingalpha.com/news/3264665-amyrisminus-38-on-planned-equity-offerings?source=tweet\" data-url=\"https://seekingalpha.com/news/3264665-amyrisminus-38-on-planned-equity-offerings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264630\" data-ts=\"1494262422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264630-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='green'>+84%</font>. <a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/GIMO' title='Gigamon, Inc.'>GIMO</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/TSEM' title='Tower Semiconductor Ltd.'>TSEM</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CGI' title='Celadon Group, Inc.'>CGI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a>&nbsp;<font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/INOD' title='Innodata Inc.'>INOD</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ARLZ-OLD' title='Aralez Pharmaceuticals Inc.'>ARLZ-OLD</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/OMEX' title='Odyssey Marine Exploration, Inc.'>OMEX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/VCYT' title='Veracyte, Inc.'>VCYT</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/BETR' title='Amplify Snack Brands'>BETR</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264630\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$INPX $STRP $PETS - Midday Gainers / Losers https://seekingalpha.com/news/3264630-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3264630-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264627\" data-ts=\"1494261634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264627-fox-news-names-gambelli-new-ad-chief\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fox News names Gambelli new ad chief</a></h4><ul>   <li>Fox News (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-1.8%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-2.2%</font>) has named Marianne Gambelli its new chief of ad sales, with responsibility for Fox News and Fox Business.</li>    <li>The move is effective May 22; Gambelli previously served as chief investment officer at Horizon Media, managing a $7B portfolio. Prior to that she was president of sales and marketing at NBCUniversal.</li>    <li>In 2012, <i>Advertising Age</i> made her one of its 100 Most Influential Women in Advertising.</li>    <li>Meanwhile, parent Twenty-First Century Fox named Melody Hildebrandt its global <a href=\"https://seekingalpha.com/pr/16824841-21st-century-fox-names-melody-hildebrandt-global-chief-information-security-officer\" target=\"_blank\">chief information security officer</a>. She joins from Palantir Technologies.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264627\" data-linked=\"Fox News names Gambelli new ad chief\" data-tweet=\"$FOX $FOX $FOXA - Fox News names Gambelli new ad chief https://seekingalpha.com/news/3264627-fox-news-names-gambelli-new-ad-chief?source=tweet\" data-url=\"https://seekingalpha.com/news/3264627-fox-news-names-gambelli-new-ad-chief\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264622\" data-ts=\"1494260458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHT\" target=\"_blank\">DHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264622-dht-holdingsminus-2-after-rejecting-latest-frontline-takeover-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DHT Holdings -2% after rejecting latest Frontline takeover bid</a></h4><ul>     <li>DHT&nbsp;Holdings (<a href='https://seekingalpha.com/symbol/DHT' title='DHT Holdings, Inc.'>DHT</a> <font color='red'>-2%</font>) is lower after <a href=\"http://www.reuters.com/article/us-dht-holdings-m-a-frontline-idUSKBN18312I\" target=\"_blank\">rejecting</a> yet another takeover proposal from Frontline (<a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a> <font color='green'>+0.5%</font>), calling the $500M all-share bid \"woefully inadequate.\"</li>     <li>The initial bid, offering to issue 0.725 FRO shares in exchange for each share of DHT, was raised to a ratio of 0.8 but was again turned down.</li>     <li>DHT board's says the offer would give the company's shareholders only a 40% stake even as its assets would contribute nearly half the net asset value of a combined company and more than 45% of 2018 earnings.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264622\" data-linked=\"DHT Holdings -2% after rejecting latest Frontline takeover bid\" data-tweet=\"$DHT $DHT $FRO - DHT Holdings -2% after rejecting latest Frontline takeover bid https://seekingalpha.com/news/3264622-dht-holdingsminus-2-after-rejecting-latest-frontline-takeover-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3264622-dht-holdingsminus-2-after-rejecting-latest-frontline-takeover-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264619\" data-ts=\"1494259244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264619-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/WILC' title='G. Willi-Food International, Ltd.'>WILC</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/KATE' title='Kate Spade & Company'>KATE</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/BETR' title='Amplify Snack Brands'>BETR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/EFOI' title='Energy Focus, Inc.'>EFOI</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264619\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SGOC $NWL $WILC - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3264619-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3264619-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264614\" data-ts=\"1494257879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALXN\" target=\"_blank\">ALXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264614-alexion-pharmaceuticals-drops-after-raid-in-brazil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alexion Pharmaceuticals drops after raid in Brazil</a></h4><ul>     <li>The national police in Brazil <a href=\"https://www.bloomberg.com/news/articles/2017-05-08/alexion-is-raided-by-brazilian-police-in-sales-practices-probe\" target=\"_blank\">confirm</a> that the offices of Alexion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color='red'>-4.3%</font>) were raided as part of an investigation into the company's sales practices in the region.</li>     <li>\"We&rsquo;re aware that authorities were at the Alexion office in Brazil, they have since left and we&rsquo;re fully cooperating with the authorities,\" responds Alexion spokeswoman Kim Diamond to Bloomberg.</li><li>Barclays is out with a quick note on the development in Brazil, saying it doesn't see the issue as a \"major fundamental concern.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264614\" data-linked=\"Alexion Pharmaceuticals drops after raid in Brazil\" data-tweet=\"$ALXN - Alexion Pharmaceuticals drops after raid in Brazil https://seekingalpha.com/news/3264614-alexion-pharmaceuticals-drops-after-raid-in-brazil?source=tweet\" data-url=\"https://seekingalpha.com/news/3264614-alexion-pharmaceuticals-drops-after-raid-in-brazil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264612\" data-ts=\"1494257441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264612-tivo-to-be-exclusive-national-ad-provider-for-frontier-program-guides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TiVo to be exclusive national ad provider for Frontier program guides</a></h4><ul>   <li>TiVo (<a href=\"http://seekingalpha.com/symbol/TIVO\" target=\"_blank\">TIVO</a> <font color='red'>-1.9%</font>) has renewed its intellectual property license deal with Frontier Communications (NYSE:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) along with a multi-year product license agreement.</li>    <li>That deal makes TiVo the <a href=\"https://seekingalpha.com/pr/16824213-tivo-renews-long-term-product-intellectual-property-license-deal-frontier-communications\" target=\"_blank\">exclusive provider</a> of national ad campaigns in interactive program guides (listings grids) on Frontier, and gives Frontier a license to TiVo's IP portfolios. Those ad campaigns will be targeted based on demographics.</li>    <li>TiVo Advertising features a number of options, including \"tune-in promotions, recording reminders and watch now for video on demand (NASDAQ:<a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a>).\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264612\" data-linked=\"TiVo to be exclusive national ad provider for Frontier program guides\" data-tweet=\"$FTR $FTR $VOD - TiVo to be exclusive national ad provider for Frontier program guides https://seekingalpha.com/news/3264612-tivo-to-be-exclusive-national-ad-provider-for-frontier-program-guides?source=tweet\" data-url=\"https://seekingalpha.com/news/3264612-tivo-to-be-exclusive-national-ad-provider-for-frontier-program-guides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264611\" data-ts=\"1494257375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALXN\" target=\"_blank\">ALXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264611-alexion-pharma-plunges-on-report-of-brazilian-office-raid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alexion Pharma plunges on report of Brazilian office raid</a></h4><ul>     <li>Alexion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color='red'>-3.7%</font>) sinks in reaction to a Bloomberg report that the company's offices in S&atilde;o Paulo have been <a href=\"https://www.bloomberg.com/news/articles/2017-05-08/alexion-is-raided-by-brazilian-police-in-sales-practices-probe\" target=\"_blank\">raided by Brazilian authorities</a>.</li>     <li>The offices were raided by authorities as part of an investigation into ALXN's sales practices, Bloomberg says, citing an emailed statement from Brazil's national police.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264611\" data-linked=\"Alexion Pharma plunges on report of Brazilian office raid\" data-tweet=\"$ALXN - Alexion Pharma plunges on report of Brazilian office raid https://seekingalpha.com/news/3264611-alexion-pharma-plunges-on-report-of-brazilian-office-raid?source=tweet\" data-url=\"https://seekingalpha.com/news/3264611-alexion-pharma-plunges-on-report-of-brazilian-office-raid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264586\" data-ts=\"1494255675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264586-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ARLZ-OLD' title='Aralez Pharmaceuticals Inc.'>ARLZ-OLD</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264586\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$PETS $OCUL $AXSM - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3264586-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3264586-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264601\" data-ts=\"1494255239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/K\" target=\"_blank\">K</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264601-kellogg-shoots-up-on-berkshire-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kellogg shoots up on Berkshire chatter</a></h4><ul> <li>Shares of Kellogg (NYSE:<a href='https://seekingalpha.com/symbol/K' title='Kellogg Company'>K</a>) are <font color='green'>up 1.63%</font> amid trader chatter indicating that Berkshire Hathaway is considering making a bid for the food company.</li> <li>The speculation is not tied to anything specific that Warren Buffett or Charlie Munger said over the weekend.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3264390-berkshire-hathaway-shareholder-meeting-live-blog\" target=\"_blank\">Berkshire Hathaway Shareholder Meeting Live Blog</a> (May 6)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3264601\" data-linked=\"Kellogg shoots up on Berkshire chatter\" data-tweet=\"$K - Kellogg shoots up on Berkshire chatter https://seekingalpha.com/news/3264601-kellogg-shoots-up-on-berkshire-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3264601-kellogg-shoots-up-on-berkshire-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264598\" data-ts=\"1494254833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AU\" target=\"_blank\">AU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264598-anglogoldminus-3-q1-profit-shrinks-south-african-output-falls-costs-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AngloGold -3% as Q1 profit shrinks; South African output falls, costs rise</a></h4><ul>     <li>AngloGold Ashanti (<a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color='red'>-3.1%</font>) is lower after reporting a 17% Y/Y decline in <a href=\"http://www.anglogoldashanti.com/en/Media/news/Pages/20170508_Q12017Release.aspx\" target=\"_blank\">Q1 profit</a> as its South African production fell and costs rose.</li>     <li>AU's Q1 EBITDA came in at $314M, down from $378M in the same period a year ago, saying \"an added focus on a safe start-up contributed to an unusually slow ramp-up after the year-end break.\"</li>     <li>AU says Q1 all-in sustaining costs <a href=\"https://www.bloomberg.com/news/articles/2017-05-08/anglogold-ashanti-profit-falls-after-south-africa-cost-blowout\" target=\"_blank\">soared 44%</a> Y/Y to $1,327/oz., mostly because of the strengthening of the South African rand; on a constant-currency basis, costs rose ~7%.</li>     <li>Even with no fatalities in the quarter, AU says overall Q1 production fell 3.6% Y/Y to 830K oz. at AISC of $1,216/oz., but the miner stuck to its FY 2017 output forecast of 3.6M-3.75M oz. and all-in sustaining costs of $1,050-$1,100/oz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264598\" data-linked=\"AngloGold -3% as Q1 profit shrinks; South African output falls, costs rise\" data-tweet=\"$AU - AngloGold -3% as Q1 profit shrinks; South African output falls, costs rise https://seekingalpha.com/news/3264598-anglogoldminus-3-q1-profit-shrinks-south-african-output-falls-costs-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/3264598-anglogoldminus-3-q1-profit-shrinks-south-african-output-falls-costs-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264595\" data-ts=\"1494253844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETS\" target=\"_blank\">PETS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264595-petmex-express-jumps-to-all-time-high-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PetMex Express jumps to all-time high after earnings</a></h4><ul> <li>PetMed Express (<a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='green'>+15.4%</font>) races higher after the company cruises past estimates with its <a href=\"https://seekingalpha.com/pr/16824256-petmed-express-inc-d-b-1minus-800-petmeds-announces-financial-results-fiscal-2017-quarterly\" target=\"_blank\">Q1 report</a>.</li> <li>A shift in product mix toward higher margin items helped push up the company's gross margin rate to 35.1% vs. 31.9% a year ago.</li> <li>Averager order size increased 3.6% Y/Y to $86 during the quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3264512-petmed-express-beats-0_11-beats-revenue\" target=\"_blank\">PetMed Express beats by $0.11, beats on revenue</a> (May 8)</li> <li>Shares of PETM carved out a new all-time high of $28.23 earlier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264595\" data-linked=\"PetMex Express jumps to all-time high after earnings\" data-tweet=\"$PETS - PetMex Express jumps to all-time high after earnings https://seekingalpha.com/news/3264595-petmex-express-jumps-to-all-time-high-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3264595-petmex-express-jumps-to-all-time-high-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264592\" data-ts=\"1494252907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITE\" target=\"_blank\">KITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264592-kite-pharmaminus-11-patient-dies-in-kte-c19-safety-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kite Pharma -11% as patient dies in KTE-C19 safety study</a></h4><ul>     <li>Kite Pharma (<a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a> <font color='red'>-11.3%</font>) plunges in early trading after reporting a larger than expected <a href=\"https://seekingalpha.com/news/3264539-kite-pharma-reports-q1-results-shares-5-percent-premarket\" target=\"_blank\">Q1 loss</a> and a patient death in safety study testing of its lead product candidate, its KTE-C19 cancer drug.</li>     <li>Kite reveals in its <a href=\"https://seekingalpha.com/filing/3537865\" target=\"_blank\">latest 10-Q</a> that one of 30 patients in a safety expansion cohort developed multiple organ failure and then fatal cerebral edema; Kite says the incident was the first grade 5 cerebral edema event that has occurred in ~200 patients who have been treated in the ZUMA clinical trials.</li>     <li>Separately, Kite says it completed BLA submission to the  FDA for axicabtagene ciloleucel in patients with aggressive NHL.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264592\" data-linked=\"Kite Pharma -11% as patient dies in KTE-C19 safety study\" data-tweet=\"$KITE - Kite Pharma -11% as patient dies in KTE-C19 safety study https://seekingalpha.com/news/3264592-kite-pharmaminus-11-patient-dies-in-kte-c19-safety-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3264592-kite-pharmaminus-11-patient-dies-in-kte-c19-safety-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264591\" data-ts=\"1494252717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JW.A\" target=\"_blank\">JW.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264591-john-wiley-sons-ceo-resigns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">John Wiley &amp; Sons CEO resigns</a></h4><ul> <li>John Wiley &amp; Sons (<a href='https://seekingalpha.com/symbol/JW.A' title='John Wiley & Sons, Inc.'>JW.A</a>, <a href='https://seekingalpha.com/symbol/JW.B' title='John Wiley & Sons Inc.'>JW.B</a>) announces the resignation of &nbsp;CEO Mark Allin&nbsp;for family reasons, effective immediately.</li><li>The company says Chairman Matthew Kissner will serve as the&nbsp;interim CEO while a search for a full-time replacement takes place.</li><li>Shares of John Wiley are&nbsp;<font color='red'>down 2.05%</font>.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16824212-mark-allin-resigns-president-ceo-wiley\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3264591\" data-linked=\"John Wiley &amp; Sons CEO resigns\" data-tweet=\"$JW.A $JW.A $JW.B - John Wiley &amp; Sons CEO resigns https://seekingalpha.com/news/3264591-john-wiley-sons-ceo-resigns?source=tweet\" data-url=\"https://seekingalpha.com/news/3264591-john-wiley-sons-ceo-resigns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264589\" data-ts=\"1494252603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFASY\" target=\"_blank\">GFASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264589-gafisa-plunges-on-moodys-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gafisa plunges on Moody&#39;s downgrade</a></h4><ul><li>Moody's America Latina <a href=\"https://www.moodys.com/research/Moodys-downgrades-Gafisas-ratings-to-B3B2br-with-a-negative-outlook--PR_366035?WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170505_PR_366035&amp;yptr=yahoo\" target=\"_blank\">downgraded</a> Gafisa's (GFA <font color='red'>-10.4%</font>) corporate family ratings and senior secured ratings, while keeping their outlook at negative.</li><li>Reason: It follows the conclusion of the sale of 50% of Construtora Tenda and spinoff of the remaining 50% to Gafisa's shareholders, which weakens the company's business profile and growth potential in the medium term.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264589\" data-linked=\"Gafisa plunges on Moody&#39;s downgrade\" data-tweet=\"$GFASY - Gafisa plunges on Moody&#39;s downgrade https://seekingalpha.com/news/3264589-gafisa-plunges-on-moodys-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3264589-gafisa-plunges-on-moodys-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264587\" data-ts=\"1494251939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BP\" target=\"_blank\">BP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264587-bp-kosmos-energy-make-major-gas-find-offshore-senegal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BP, Kosmos Energy make major gas find offshore Senegal</a></h4><ul>     <li>BP (<a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color='green'>+0.1%</font>) and joint venture partner Kosmos Energy (<a href='https://seekingalpha.com/symbol/KOS' title='Kosmos Energy'>KOS</a> <font color='green'>+19%</font>) announce a <a href=\"http://www.bp.com/en/global/corporate/media/press-releases/bp-announces-major-gas-find-offshore-senegal.html\" target=\"_blank\">major gas discovery offshore Senegal</a>.</li>     <li>BP says the Yakaar-1 exploration well \"follows the earlier exploration success that led to the Tortue discovery and further confirms our belief that offshore Senegal and Mauritania is a world-class hydrocarbon basin.\"</li>     <li>BP says the Yakaar discovery, coupled with the Teranga discovery, creates the foundation for a further liquefied natural gas hub in the basin.</li><li>The companies say they plan to drill three additional exploration wells over the next 12 months offshore Senegal and Mauritania.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264587\" data-linked=\"BP, Kosmos Energy make major gas find offshore Senegal\" data-tweet=\"$BP $BP $KOS - BP, Kosmos Energy make major gas find offshore Senegal https://seekingalpha.com/news/3264587-bp-kosmos-energy-make-major-gas-find-offshore-senegal?source=tweet\" data-url=\"https://seekingalpha.com/news/3264587-bp-kosmos-energy-make-major-gas-find-offshore-senegal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264577\" data-ts=\"1494250996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STRP\" target=\"_blank\">STRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264577-cnbc-straight-path-3_1b-offer-is-from-verizon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC: Straight Path $3.1B offer is from Verizon</a></h4><ul>   <li>Straight Path Communications' (<a href=\"http://seekingalpha.com/symbol/STRP\" target=\"_blank\">STRP</a> <font color='green'>+26.3%</font>) latest <a href=\"https://seekingalpha.com/news/3264534-straight-path-gets-another-buyout-bid\" target=\"_blank\">topping offer</a> of about $184/share from a \"multinational telecommunications company\" is from Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='red'>-0.3%</font>), CNBC's David Faber says.</li>    <li>If so, is Verizon bidding against itself? A lifted bid of <a href=\"https://seekingalpha.com/news/3262669-straight-path-plus-19-percent-revised-offer-mystery-suitor\" target=\"_blank\">$135.96/share</a> last Wednesday was assumed to be Verizon, and expected buyer AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='red'>-0.3%</font>) has yet to post a new definitive deal from its $95.63/share agreement.</li>    <li>The fact that the new deals are \"superior proposals\" set AT&amp;T up for counterbidding, and executives say the company had five business days to respond on whether to increase its offer. The apparent outcome is a pitched battle between the two U.S. wireless leaders for the prized millimeter wave spectrum that Straight Path is sitting on.</li>    <li>Straight Path is <font color='green'>up 26.3%</font> to $204, well above the $184/share offer, indicating investors have popcorn ready for the next move (and are expecting another bid to come).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264577\" data-linked=\"CNBC: Straight Path $3.1B offer is from Verizon\" data-tweet=\"$STRP $STRP $VZ - CNBC: Straight Path $3.1B offer is from Verizon https://seekingalpha.com/news/3264577-cnbc-straight-path-3_1b-offer-is-from-verizon?source=tweet\" data-url=\"https://seekingalpha.com/news/3264577-cnbc-straight-path-3_1b-offer-is-from-verizon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264572\" data-ts=\"1494250730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STMP\" target=\"_blank\">STMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264572-pitney-bowes-goes-right-stamps-com\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pitney Bowes goes right at Stamps.com</a></h4><ul>     <li>There's a downward swing for Stamps.com (<a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a> <font color='red'>-5.9%</font>) after Pitney Bowes (<a href='https://seekingalpha.com/symbol/PBI' title='Pitney Bowes Inc.'>PBI</a> <font color='green'>+0.1%</font>) announces a new $5 per month cloud-based SendPro mailing and shipping solution.</li>     <li>\"SendPro delivers three times the benefits for small and medium businesses at one-third the cost of Stamps.com,\" says Pitney Bowes in a bit of shade thrown at STMP.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16824583-pitney-bowes-announces-new-sendpro-5-offering-delivering-3x-benefits-one-third-cost-stamps\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3264572\" data-linked=\"Pitney Bowes goes right at Stamps.com\" data-tweet=\"$STMP $STMP $PBI - Pitney Bowes goes right at Stamps.com https://seekingalpha.com/news/3264572-pitney-bowes-goes-right-stamps-com?source=tweet\" data-url=\"https://seekingalpha.com/news/3264572-pitney-bowes-goes-right-stamps-com\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264565\" data-ts=\"1494250167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264565-jd-complus-6-all-time-high-after-surprise-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com +6%, at all-time high after surprise profit</a></h4><ul>   <li>JD.com (NASDAQ:<a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a>) is <font color='green'>up 6%</font> and for its all-time high after posting a surprise profit in its <a href=\"https://seekingalpha.com/news/3264421-jd-com-beats-0_14-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li>    <li>The company swung to a gain from operations of 843.1M yuan (about $122.5M), vs. a loss of 864.9M yuan a year ago.</li>    <li>Active customer accounts rose by 40% to 236.5M in the past 12 months, from a year-ago 169.1M. Fulfilled orders came to 477.1M (up 39%). Fulfilled orders through mobile made up 81% of total (up 56%).</li>    <li>Revenues by segment: JD Mall, $10.9B (up 39.5% in renminbi terms); New Businesses, $280.7M (up 166%); inter-segment, -$114.2M.</li>    <li>Cash and equivalents came to 35B yuan (about $5.1B); net cash from operations was $637.6M, and free cash flow was $601.9M.</li>    <li>It's guiding to Q2 revenues of 88B yuan to 90.5B yuan (growth of about 35-39% Y/Y). Excluding JD Finance, they're expected at 86.6B-89.1B yuan (33-37% growth).</li>    <li><a href=\"https://seekingalpha.com/pr/16823888-jd-com-announces-first-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3264565\" data-linked=\"JD.com +6%, at all-time high after surprise profit\" data-tweet=\"$JD - JD.com +6%, at all-time high after surprise profit https://seekingalpha.com/news/3264565-jd-complus-6-all-time-high-after-surprise-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3264565-jd-complus-6-all-time-high-after-surprise-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264563\" data-ts=\"1494249946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264563-array-biopharma-merck-to-study-binimetinib-and-keytruda-combo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Array BioPharma, Merck to study binimetinib and Keytruda combo</a></h4><ul>     <li>Array Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a>) <font color='green'>+2.3%</font> premarket on news it will <a href=\"https://seekingalpha.com/pr/16824133-array-biopharma-announces-strategic-collaboration-merck\" target=\"_blank\">collaborate on a clinical trial</a> with Merck (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) to investigate the safety and efficacy of its binimetinib MEK&nbsp;inhibitor with MRK's Keytruda anti-PD-1 therapy in metastatic colorectal cancer patients with microsatellite stable tumors.</li><li>The companies say the trial, to be sponsored by MRK, will attempt to establish a recommended dose regimen of  binimetinib and Keytruda, as well as explore the preliminary anti-tumor  activity of several novel regimens.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264563\" data-linked=\"Array BioPharma, Merck to study binimetinib and Keytruda combo\" data-tweet=\"$ARRY $ARRY $MRK - Array BioPharma, Merck to study binimetinib and Keytruda combo https://seekingalpha.com/news/3264563-array-biopharma-merck-to-study-binimetinib-and-keytruda-combo?source=tweet\" data-url=\"https://seekingalpha.com/news/3264563-array-biopharma-merck-to-study-binimetinib-and-keytruda-combo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264562\" data-ts=\"1494249927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264562-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+27%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3264534-straight-path-gets-another-buyout-bid\" target=\"_blank\">receiving</a> another buy-out bid.</li><li><a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a> <font color='green'>+15%</font>&nbsp;<a href=\"https://seekingalpha.com/pr/16824010-axsome-therapeutics-receives-fda-fast-track-designation-axsminus-05-alzheimer-s-disease\" target=\"_blank\">received</a> Fast Track designation from the U.S. Food and Drug Administration for AXS-05 for the treatment of agitation in patients with Alzheimer&rsquo;s disease.</li><li><a href='https://seekingalpha.com/symbol/GIMO' title='Gigamon, Inc.'>GIMO</a> <font color='green'>+11%</font>.</li><li><a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='green'>+10%</font>&nbsp;to <a href=\"https://seekingalpha.com/pr/16824387-municipal-utility-turning-clean-affordable-fuel-cells-meet-power-resiliency-needs\" target=\"_blank\">execute</a> a power purchase agreement for the long-term supply of power.</li><li><a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a> <font color='green'>+9%</font>. on Q1 <a href=\"https://seekingalpha.com/news/3264440-newell-brands-beats-0_05-beats-revenue\" target=\"_blank\">result</a></li><li><a href='https://seekingalpha.com/symbol/KATE' title='Kate Spade & Company'>KATE</a> <font color='green'>+8%</font>. on being <a href=\"https://seekingalpha.com/news/3264454-coach-buy-kate-spade-2_4b\" target=\"_blank\">acquired</a> by Coach (COH).</li><li><a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/TSEM' title='Tower Semiconductor Ltd.'>TSEM</a> <font color='green'>+7%</font>. on Q1 <a href=\"https://seekingalpha.com/news/3264439-tower-semiconductor-beats-0_06-revenue-line\" target=\"_blank\">result</a>.</li><li>COH <font color='green'>+6%</font>. on <a href=\"https://seekingalpha.com/news/3264454-coach-buy-kate-spade-2_4b\" target=\"_blank\">acquiring</a> (NYSE:<a href='https://seekingalpha.com/symbol/KATE' title='Kate Spade & Company'>KATE</a>)</li><li><a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a> <font color='green'>+6%</font>. on Q1 <a href=\"https://seekingalpha.com/news/3264421-jd-com-beats-0_14-beats-revenue\" target=\"_blank\">result</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264562\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$STRP $AXSM $GIMO - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3264562-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3264562-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264558\" data-ts=\"1494249360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRRX\" target=\"_blank\">DRRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264558-durect-higher-after-development-deal-novartis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Durect higher after development deal with Novartis</a></h4><ul> <li>Durect Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a>)&nbsp;<font color='green'>shoots up 38%</font>&nbsp;in premarket action after announcing a development and commercialization agreement with Novartis division Sandoz AG to develop and market Posimir&nbsp;in the U.S..</li>  <li>Previously: <a href=\"https://seekingalpha.com/news/3264484-durect-novartis-sign-293m-u-s-development-marketing-deal-posimir\" target=\"_blank\">Durect, Novartis sign $293M U.S. development, marketing deal for Posimir</a> (May 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3264558\" data-linked=\"Durect higher after development deal with Novartis\" data-tweet=\"$DRRX - Durect higher after development deal with Novartis https://seekingalpha.com/news/3264558-durect-higher-after-development-deal-novartis?source=tweet\" data-url=\"https://seekingalpha.com/news/3264558-durect-higher-after-development-deal-novartis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264554\" data-ts=\"1494249127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264554-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a>&nbsp;<font color='red'>-31%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3264469-horizon-pharma-misses-0_02-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3264538-therapeuticsmd-address-fda-concerns-txminus-004hr\" target=\"_blank\">concerns</a> regarding TX-004HR</li><li><a href='https://seekingalpha.com/symbol/CS' title='Credit Suisse Group AG'>CS</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3264513-kite-pharma-misses-0_02-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3264554\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$HZNP $TXMD $CS - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3264554-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3264554-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264552\" data-ts=\"1494248949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264552-sinclair-broadcast-announces-3_9b-deal-for-tribune-media\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair Broadcast announces $3.9B deal for Tribune Media</a></h4><ul>   <li>Sinclair Broadcast Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SBGI' title='Sinclair Broadcast Group, Inc.'>SBGI</a>) confirms it's <a href=\"https://seekingalpha.com/pr/16824456-sinclair-broadcast-group-acquire-tribune-media-company-approximately-3_9-billion\" target=\"_blank\">acquiring Tribune Media</a> (NYSE:<a href='https://seekingalpha.com/symbol/TRCO' title='Tribune Media Company'>TRCO</a>) for $3.9B, creating a local broadcasting juggernaut.</li>    <li>In the definitive deal, Tribune shareholders get $35 in cash and 0.23 shares of Sinclair Class A stock for each share of Tribune common stock they own, for consideration of $43.50/share.</li>    <li>Tribune shares are <font color='green'>up 4.2%</font> premarket, to $42/share.</li>    <li>Tribune owns or operates 42 stations in 33 markets along with national station WGN America.</li>    <li>Including Tribune and other transactions and pro forma for expected synergies, Sinclair's 2015 and 2016 media revenues would have been $4.07B and $4.6B respectively.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264552\" data-linked=\"Sinclair Broadcast announces $3.9B deal for Tribune Media\" data-tweet=\"$SBGI $SBGI $TRCO - Sinclair Broadcast announces $3.9B deal for Tribune Media https://seekingalpha.com/news/3264552-sinclair-broadcast-announces-3_9b-deal-for-tribune-media?source=tweet\" data-url=\"https://seekingalpha.com/news/3264552-sinclair-broadcast-announces-3_9b-deal-for-tribune-media\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264547\" data-ts=\"1494248593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264547-tyson-foods-down-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson Foods down post Q2 results</a></h4><ul>     <li>Tyson Foods (NYSE:<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a>)&nbsp;reports total sales volume fell 1.9% in <a href=\"https://seekingalpha.com/pr/16824105-tyson-foods-generates-record-first-six-months-gaap-eps-rises-12-percent-17-percent-adjusted\" target=\"_blank\">Q2</a>.</li>     <li>Segment Sales: Chicken: $2.8B (+2.2%); Beef: $3.49B (-4.2%); Pork: $1.3B (+9.4%); Prepared Foods: $1.75B (-2.9%); Other: $82M (-4.7%).</li>     <li>Segment Volume change: Chicken: -2%; Beef: -1.1%; Pork: -1.3%; Prepared Foods: -2.1%; Other:+3%.</li>     <li>Segment Average Price change: Chicken: +4.3%; Beef: -3.1%; Pork: +10.9%; Prepared Foods: -0.8%; Other: -7.8%.</li>     <li>Gross margin rate squeezed 140 bps to 11.5%.</li>     <li>SG&amp;A expense rate flat Y/Y at 5.2%.</li>     <li>Adjusted operating margin rate slipped 80 bps to 6.9%.</li>     <li>The company expects domestic protein production to increase ~3% to 4% Y/Y in FY2017.</li>     <li><b>FY2017 Guidance</b>: Sales: flat Y/Y; Chicken&nbsp;operating margin: normalized range of 9% to 11%; Beef operating margin: ~5%;&nbsp;Pork operating&nbsp;margin:&nbsp;~ 12%; Prepared Foods&nbsp;operating margin:&nbsp;~9%;&nbsp;Other operating loss: ~$70M;&nbsp;Adjusted EPS: $4.90 - $5.05; Capital expenditure:&nbsp;~1B; Net interest&nbsp;expense: ~$275M; Liquidity: in range of $1B.</li>     <li>TSN&nbsp;<font color='red'>-2.10%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264547\" data-linked=\"Tyson Foods down post Q2 results\" data-tweet=\"$TSN - Tyson Foods down post Q2 results https://seekingalpha.com/news/3264547-tyson-foods-down-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3264547-tyson-foods-down-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264540\" data-ts=\"1494247872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTTI\" target=\"_blank\">VTTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264540-vtti-energy-partners-agrees-to-increased-offer-to-be-bought-vtti-b-v\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VTTI Energy Partners agrees to increased offer to be bought by VTTI B.V.</a></h4><ul><li>VTTI Energy Partners (NYSE:<a href='https://seekingalpha.com/symbol/VTTI' title='VTTI Energy Partners LP'>VTTI</a>) <font color='green'>+4.3%</font> premarket after <a href=\"https://seekingalpha.com/pr/16823907-vtti-energy-partners-lp-announces-agreement-vtti-b-v-acquire-publicly-held-common-units\" target=\"_blank\">agreeing an to increased offer to be acquired</a> by VTTI B.V. at $19.50/unit for an aggregate value of ~$481M; the revised price is $0.75 higher than the $18.75 offer <a href=\"https://seekingalpha.com/news/3248356-vtti-energy-partners-gets-18_75-unit-buyout-offer-vtti-b-v\" target=\"_blank\">made on March 2</a>.</li><li>VTTI says unitholders will continue to receive regular  quarterly distributions of $0.336/unit for each completed quarter  prior to the closing date, which is expected in Q3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264540\" data-linked=\"VTTI Energy Partners agrees to increased offer to be bought by VTTI B.V.\" data-tweet=\"$VTTI - VTTI Energy Partners agrees to increased offer to be bought by VTTI B.V. https://seekingalpha.com/news/3264540-vtti-energy-partners-agrees-to-increased-offer-to-be-bought-vtti-b-v?source=tweet\" data-url=\"https://seekingalpha.com/news/3264540-vtti-energy-partners-agrees-to-increased-offer-to-be-bought-vtti-b-v\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264539\" data-ts=\"1494247842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITE\" target=\"_blank\">KITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264539-kite-pharma-reports-q1-results-shares-off-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kite Pharma reports Q1 results; shares off 5% premarket</a></h4><ul><li>Kite Pharma (<a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a>) <a href=\"https://seekingalpha.com/pr/16824181-kite-reports-first-quarter-financial-results\" target=\"_blank\">Q1 results</a>: Revenues: $9.8M (+92.2%); Operating Loss: ($91.9M); Net Loss: ($90.4M); Loss Per Share: ($1.74); Quick Assets: $804M (+94.0%).</li><li><strong>2017 Guidance</strong>: Net Cash Burn: $325M - 340M; GAAP Operating Expenses: $490M - 515M.</li><li>Shares are down&nbsp;<font color='red'>5%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264539\" data-linked=\"Kite Pharma reports Q1 results; shares off 5% premarket\" data-tweet=\"$KITE - Kite Pharma reports Q1 results; shares off 5% premarket https://seekingalpha.com/news/3264539-kite-pharma-reports-q1-results-shares-off-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3264539-kite-pharma-reports-q1-results-shares-off-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264538\" data-ts=\"1494247775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264538-therapeuticsmd-to-address-fda-concerns-on-txminus-004hr\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TherapeuticsMD to address FDA concerns on TX-004HR</a></h4><ul> <li>TherapeuticsMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>) says it plans to meet with the FDA as soon as possible to address concerns raised in a response letter regarding the new drug application for TX-004HR.</li><li>TX-004HR is the company&rsquo;s investigational       applicator-free estradiol vaginal softgel capsule for the treatment of       moderate-to-severe vaginal pain.</li>     <li>&ldquo;While we are disappointed that the NDA for TX-004HR was not approved at       this time and respectfully disagree with the FDA&rsquo;s decision, we believe       there are multiple paths forward to address the concerns raised by the       FDA,\" reads a statement by CEO&nbsp;&nbsp;Robert Finizio.</li><li>TXMD  <font color='red'>-11.14%</font> premarket to  $4.15.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16824125-therapeuticsmd-receives-complete-response-letter-fda-txminus-004hr-new-drug-application\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3264538\" data-linked=\"TherapeuticsMD to address FDA concerns on TX-004HR\" data-tweet=\"$TXMD - TherapeuticsMD to address FDA concerns on TX-004HR https://seekingalpha.com/news/3264538-therapeuticsmd-to-address-fda-concerns-on-txminus-004hr?source=tweet\" data-url=\"https://seekingalpha.com/news/3264538-therapeuticsmd-to-address-fda-concerns-on-txminus-004hr\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264537\" data-ts=\"1494247708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264537-micron-slips-after-goldman-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron slips after Goldman downgrade</a></h4><ul><li>Goldman downgraded the chipmaker to Neutral from Buy, <a href=\"https://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+Micron+Technology+%28MU%29+to+Neutral/12868954.html\" target=\"_blank\">saying</a> the catalysts it had anticipated with its original rating have now materialized and are built into the stock's price.</li><li>Among them: improved prices for memory chips and bigger profit margins.</li><li>The firm also lowered its price target on the stock to $30 (from $32).</li><li><a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='red'>-2.7%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3264537\" data-linked=\"Micron slips after Goldman downgrade\" data-tweet=\"$MU - Micron slips after Goldman downgrade https://seekingalpha.com/news/3264537-micron-slips-after-goldman-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3264537-micron-slips-after-goldman-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264535\" data-ts=\"1494247496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264535-evercore-confident-on-tesla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore confident on Tesla</a></h4><ul> <li>Evercore ISI picks up <a href=\"http://www.cnbc.com/2017/05/08/early-movers-cmcsa-chtr-kate-coh-strp-nwl-mu-tsn-mnk-amzn-more.html\" target=\"_blank\">coverage</a> again on Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) with an Outperform rating and $330 price target after being ratings restricted since serving as an advisor on the SolarCity merger.</li> <li>The firm forecasts that Tesla will hit its 500K unit target at the of Q1 in 2019 on a rolling 12-month view. The long-term view on the stock is that it's an \"extreme growth\" story.</li> <li>Shares of Tesla are <font color='green'>up 0.76%</font> premarket to $310.70 vs. a 52-week trading range of $178.19 to $327.66.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3264535\" data-linked=\"Evercore confident on Tesla\" data-tweet=\"$TSLA - Evercore confident on Tesla https://seekingalpha.com/news/3264535-evercore-confident-on-tesla?source=tweet\" data-url=\"https://seekingalpha.com/news/3264535-evercore-confident-on-tesla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>85&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264533\" data-ts=\"1494247025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264533-therapeuticsmds-vaginal-pain-drug-rejected-fda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TherapeuticsMD&#39;s vaginal pain drug rejected by FDA</a></h4><ul>     <li>TherapeuticsMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>) <font color='red'>-11.3%</font> premarket after saying the FDA <a href=\"https://seekingalpha.com/pr/16824125-therapeuticsmd-receives-complete-response-letter-fda-txminus-004hr-new-drug-application\" target=\"_blank\">rejected</a> its application to market its TX-004HR drug to treat vaginal pain.</li>     <li>TXMD says the FDA identified issues relating to long-term safety data but not to the efficacy of the drug and did not identify any approvability issues related to chemistry, manufacturing and controls.</li>     <li>TXMD believes the new drug application was approvable as filed and intends to meet with the FDA as soon as possible to address the agency's concerns.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264533\" data-linked=\"TherapeuticsMD&#39;s vaginal pain drug rejected by FDA\" data-tweet=\"$TXMD - TherapeuticsMD&#39;s vaginal pain drug rejected by FDA https://seekingalpha.com/news/3264533-therapeuticsmds-vaginal-pain-drug-rejected-fda?source=tweet\" data-url=\"https://seekingalpha.com/news/3264533-therapeuticsmds-vaginal-pain-drug-rejected-fda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264526\" data-ts=\"1494246573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGYP\" target=\"_blank\">SGYP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264526-synergy-pharmaceuticals-presents-trulance-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synergy Pharmaceuticals presents Trulance data</a></h4><ul> <li>Shares of Synergy Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a>) are on watch as the company presents <a href=\"https://seekingalpha.com/pr/16823814-synergy-pharmaceuticals-present-trulance-plecanatide-phase-3-data-digestive-disease-week-ddw\" target=\"_blank\">new data</a> for on-market constipation drug Trulance at a medical conference.</li> <li>Trulance is a once-daily tablet approved by the FDA for the treatment of adults with chronic idiopathic constipation and is currently being evaluated for the treatment of adults with IBS-C.</li> <li>Over 12 weeks of testing of Trulance indicated a \"significantly greater efficacy responder rate\" for the treatment.</li> <li>SGYP <font color='green'>+2.50%</font> premarket to $4.10.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264526\" data-linked=\"Synergy Pharmaceuticals presents Trulance data\" data-tweet=\"$SGYP $SGYP-OLD - Synergy Pharmaceuticals presents Trulance data https://seekingalpha.com/news/3264526-synergy-pharmaceuticals-presents-trulance-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3264526-synergy-pharmaceuticals-presents-trulance-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264522\" data-ts=\"1494245769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264522-melco-resorts-lower-crown-exits-position\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Melco Resorts lower as Crown exits position</a></h4><ul> <li>Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>) trades lower after 15.8M ADSs were offered up by bankers as part of the exit by Crown Resorts (<a href='https://seekingalpha.com/symbol/CWLDF' title='Crown Resorts Ltd.'>OTCPK:CWLDF</a>, <a href='https://seekingalpha.com/symbol/CWLDY' title='Crown Resorts Ltd. ADR'>OTCPK:CWLDY</a>) from its position in the casino operator.</li> <li>The price range on the block is reported by Bloomberg to be $21.25 to $21.45 per ADS.</li> <li>MLCO <font color='red'>-4.21%</font> premarket to $21.40.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3264522\" data-linked=\"Melco Resorts lower as Crown exits position\" data-tweet=\"$MLCO $MLCO $CWLDF - Melco Resorts lower as Crown exits position https://seekingalpha.com/news/3264522-melco-resorts-lower-crown-exits-position?source=tweet\" data-url=\"https://seekingalpha.com/news/3264522-melco-resorts-lower-crown-exits-position\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264518\" data-ts=\"1494245301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264518-tyson-foods-discloses-florida-ag-info-demand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson Foods discloses Florida AG info demand</a></h4><ul> <li>Tyson Foods (NYSE:<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a>) discloses in a SEC filing that it received a civil investigative demand from the Florida Attorney General.</li> <li>The requests asks the company for information related to the Georgia Dock chicken products index.</li> <li>Management is hosting a conference call at 9:00 A.M. ET to discuss earnings and the Florida probe.</li> <li><a href=\"https://seekingalpha.com/filing/3537737\" target=\"_blank\">SEC From 10-Q</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3264494-tyson-foods-misses-0_01-beats-revenue\" target=\"_blank\">Tyson Foods misses by $0.01, beats on revenue</a> (May 8)</li> <li>Shares of Tyson are <font color='red'>down 2.10%</font> premarket to $62.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264518\" data-linked=\"Tyson Foods discloses Florida AG info demand\" data-tweet=\"$TSN - Tyson Foods discloses Florida AG info demand https://seekingalpha.com/news/3264518-tyson-foods-discloses-florida-ag-info-demand?source=tweet\" data-url=\"https://seekingalpha.com/news/3264518-tyson-foods-discloses-florida-ag-info-demand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264503\" data-ts=\"1494244678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXSM\" target=\"_blank\">AXSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264503-axsome-therapeutics-lands-fda-fast-track-designation-for-alzheimer-s-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axsome Therapeutics lands FDA fast track designation for Alzheimer\u2019s treatment</a></h4><ul> <li>Axsome Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a>) announces that it landed fast track designation from the FDA for Alzheimer&rsquo;s disease treament AXS-05.</li><li>The company notes that there are currently no approved treatments for the condition of agitation in patients.</li><li>Axsome previously received Investigational New Drug Application clearance from the FDA to proceed with a Phase 2/3 trial of AXS-05 in this indication.</li><li>AXSM  <font color='green'>+16.67%</font> premarket to  $4.55.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16824010-axsome-therapeutics-receives-fda-fast-track-designation-axsminus-05-alzheimer-s-disease\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3264503\" data-linked=\"Axsome Therapeutics lands FDA fast track designation for Alzheimer\u2019s treatment\" data-tweet=\"$AXSM - Axsome Therapeutics lands FDA fast track designation for Alzheimer\u2019s treatment https://seekingalpha.com/news/3264503-axsome-therapeutics-lands-fda-fast-track-designation-for-alzheimer-s-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/3264503-axsome-therapeutics-lands-fda-fast-track-designation-for-alzheimer-s-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264501\" data-ts=\"1494244428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMED\" target=\"_blank\">OMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264501-oncomed-pharmaminus-17-after-demcizumab-clinical-trial-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoMed Pharma -17% after demcizumab clinical trial miss</a></h4><ul><li>OncoMed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/OMED' title='OncoMed Pharmaceuticals, Inc'>OMED</a>) <font color='red'>-16.9%</font> premarket after reporting <a href=\"https://seekingalpha.com/news/3264447-oncomed-beats-0_02-misses-revenue\" target=\"_blank\">Q1 results</a> and reporting that its Phase 2 demcizumab DENALI non-small cell lung cancer trial did not meet endpoints.</li><li>OMED says it is discontinuing the dosing of all patients on the demcizumab  trials and  will conduct a complete program review with its partner  Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>).</li><li>The drug was being tested as a combination treatment but  failed to meet its efficacy endpoints compared with the placebo, with  patients on the placebo demonstrating better results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3264501\" data-linked=\"OncoMed Pharma -17% after demcizumab clinical trial miss\" data-tweet=\"$OMED $OMED $CELG - OncoMed Pharma -17% after demcizumab clinical trial miss https://seekingalpha.com/news/3264501-oncomed-pharmaminus-17-after-demcizumab-clinical-trial-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3264501-oncomed-pharmaminus-17-after-demcizumab-clinical-trial-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264473\" data-ts=\"1494242319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JYMHF\" target=\"_blank\">JYMHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264473-jimmy-choo-lower-in-london-after-coach-kate-spade-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jimmy Choo lower in London after Coach-Kate Spade deal</a></h4><ul>     <li>Jimmy Choo (<a href='https://seekingalpha.com/symbol/JYMHF' title='Jimmy Choo PLC'>OTC:JYMHF</a>) trades&nbsp;<font color='red'>1.35%&nbsp;lower</font>&nbsp;in London after Coach acquires Kate Spade.</li>     <li>The British fashion house has been a rumored <a href=\"https://seekingalpha.com/news/3261531-coach-hunt-jimmy-choo\" target=\"_blank\">target</a> of Coach.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3264454-coach-buy-kate-spade-2_4b\" target=\"_blank\">Coach to buy Kate Spade for $2.4B</a> (May 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264473\" data-linked=\"Jimmy Choo lower in London after Coach-Kate Spade deal\" data-tweet=\"$JYMHF - Jimmy Choo lower in London after Coach-Kate Spade deal https://seekingalpha.com/news/3264473-jimmy-choo-lower-in-london-after-coach-kate-spade-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3264473-jimmy-choo-lower-in-london-after-coach-kate-spade-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264470\" data-ts=\"1494241908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBRA\" target=\"_blank\">SBRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264470-sabra-healthcare-reit-care-capital-properties-to-merge-in-7_4b-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sabra Healthcare REIT, Care Capital Properties to merge in $7.4B deal</a></h4><ul>     <li>Sabra Healthcare REIT (NASDAQ:<a href='https://seekingalpha.com/symbol/SBRA' title='Sabra Health Care REIT, Inc.'>SBRA</a>) and Care Capital Properties (CCP) <a href=\"https://seekingalpha.com/pr/16823836-sabra-health-care-care-capital-properties-combine-7_4-billion-transaction-create-premier\" target=\"_blank\">agree to merge</a> in an all-stock deal, creating a healthcare REit with a portfolio of 564 investments across 43 U.S. states and Canada.</li>     <li>The combined company is expected to have a pro forma total market cap of ~$7.4B and an equity market cap of ~$4.3B.</li><li>Under the deal terms, CCP shareholders will receive 1.123 shares of SBRA common stock for each share of CCP common stock they own.</li><li>SBRA's current management team of Sabra will lead the combined company,  with Rick Matros to serve as Chairman and CEO; the SBRA board will be expanded to eight members, adding CCP CEO Raymond Lewis and two additional  directors from CCP.</li><li>CCP&nbsp;<font color='green'>+5.6%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264470\" data-linked=\"Sabra Healthcare REIT, Care Capital Properties to merge in $7.4B deal\" data-tweet=\"$SBRA - Sabra Healthcare REIT, Care Capital Properties to merge in $7.4B deal https://seekingalpha.com/news/3264470-sabra-healthcare-reit-care-capital-properties-to-merge-in-7_4b-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3264470-sabra-healthcare-reit-care-capital-properties-to-merge-in-7_4b-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>143&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264453\" data-ts=\"1494241217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWL\" target=\"_blank\">NWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264453-newell-brands-higher-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newell Brands higher post Q1 results</a></h4><ul>     <li>Newell Brands (NYSE:<a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a>) reports core sales growth of 2.5% in <a href=\"https://seekingalpha.com/pr/16823973-newell-brands-announces-strong-first-quarter-results\" target=\"_blank\">Q1</a>, driven by strong growth in Baby and Appliances,&nbsp;Writing and Jostens,&nbsp;Waddington,&nbsp;Team Sports and Beverages&nbsp;and&nbsp;Process Solutions.</li>     <li>Segment net sales: Live: $1.07B (+3.8%, Core sales: +2.7%); Learn: $569.1M (+6.9%,&nbsp;Core sales: +7.6%); Work: $613.7M (-3.7%,&nbsp;Core sales: -2.9%);&nbsp;Play:&nbsp;$628M (+0.3%,&nbsp;Core sales: +0.5%); Other:&nbsp;$387.7M (-23.8%,&nbsp;Core sales: +12%).</li>     <li>Northe America net sales fell 3% to $2.45B</li>     <li>Normalized gross margin declined 410 bps to 34.5%.</li>     <li>Normalized operating margin rate squeezed 250 bps to 10.6%, due to the mix impact of the acquired Jarden business and investment in brand development, insights and e-commerce.</li>     <li><b>FY2017 Guidance</b>: Net sales: $14.52B to $14.72B (+9.5% to +11%); Core sales: +2.5% to +4%; Normalized EPS: $3 to $3.2; Tax rate: ~23%.</li>     <li>NWL&nbsp;<font color='green'>+5.63</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3264453\" data-linked=\"Newell Brands higher post Q1 results\" data-tweet=\"$NWL - Newell Brands higher post Q1 results https://seekingalpha.com/news/3264453-newell-brands-higher-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3264453-newell-brands-higher-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264440\" data-ts=\"1494239452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWL\" target=\"_blank\">NWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264440-newell-brands-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newell Brands beats by $0.05, beats on revenue</a></h4><ul><li>Newell Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a>): Q1 EPS of $0.34 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $3.27B (+149.6% Y/Y) <font color='green'>beats by $50M</font>.</li><li>Shares <font color='green'>+2.97%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16823973-newell-brands-announces-strong-first-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3264440\" data-linked=\"Newell Brands beats by $0.05, beats on revenue\" data-tweet=\"$NWL - Newell Brands beats by $0.05, beats on revenue https://seekingalpha.com/news/3264440-newell-brands-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3264440-newell-brands-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264439\" data-ts=\"1494239416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSEM\" target=\"_blank\">TSEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264439-tower-semiconductor-beats-0_06-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tower Semiconductor beats by $0.06,  revenue in-line</a></h4><ul><li>Tower Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/TSEM' title='Tower Semiconductor Ltd.'>TSEM</a>): Q1 EPS of $0.49 <font color='green'>beats by $0.06</font>.</li><li>Revenue of $330.08M (+18.7% Y/Y) in-line.</li><li>Shares <font color='green'>+3.51%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16823960-towerjazz-reports-first-quarter-2017-results-record-free-cash-flow-resulting-strong-year-year'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3264439\" data-linked=\"Tower Semiconductor beats by $0.06,  revenue in-line\" data-tweet=\"$TSEM - Tower Semiconductor beats by $0.06, revenue in-line https://seekingalpha.com/news/3264439-tower-semiconductor-beats-0_06-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3264439-tower-semiconductor-beats-0_06-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3264421\" data-ts=\"1494236516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3264421-jd-com-beats-0_14-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com beats by $0.14, beats on revenue</a></h4><ul><li>JD.com (NASDAQ:<a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a>): Q1 EPADS of $0.15 <font color='green'>beats by $0.14</font>.</li><li>Revenue of $11.07B (+41.4% Y/Y) <font color='green'>beats by $410M</font>.</li><li>Shares <font color='green'>+4.53%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/16823888-jd-com-announces-first-quarter-2017-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3264421\" data-linked=\"JD.com beats by $0.14, beats on revenue\" data-tweet=\"$JD - JD.com beats by $0.14, beats on revenue https://seekingalpha.com/news/3264421-jd-com-beats-0_14-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3264421-jd-com-beats-0_14-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":74,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}